Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
GMPS
REST API REST API
Homo sapiens
GMPS is differentially expressed in 277 experiments: 103 organism parts: cerebellum, placenta, ... (101 more);, 106 disease states: normal, control, ... (104 more);, 84 cell types 343 cell lines 43 compound treatments and 64 other conditions.
Orthologs GMPS (Gallus gallus)   Gmps (Mus musculus)   ENSCING00000016801 (Ciona intestinalis)   GUA1 (Saccharomyces cerevisiae)   GMPS (Bos taurus)   ENSCING00000005720 (Ciona intestinalis)   gmps (Danio rerio)   GUAA_RAT (Rattus norvegicus)   bur (Drosophila melanogaster)   GMPS (Xenopus laevis)   GMPS (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, ligase activity, asparagine biosynthetic process, GMP biosynthetic process, cytoplasm, glutamine metabolic process, ATP binding, tRNA processing, purine ribonucleoside monophosphate biosynthetic process, purine nucleotide biosynthetic process, asparagine synthase (glutamine-hydrolyzing) activity, GMP synthase activity, nucleotide binding, GMP synthase (glutamine-hydrolyzing) activity, biosynthetic process, transferase activity, purine base biosynthetic process, hydrolase activity, purine base metabolic process, catalytic activity, nucleobase-containing small molecule metabolic process
InterPro Term Asn_synthase, Anth_synthII, GATASE, Peptidase_C26, tRNA-specific_2-thiouridylase, NAD/GMP_synthase, GMP_synth_C, GMP_synth_N, GATASE_1, Queuosine_synthesis
UniProt Accession P49915, A8K639, B4DUT7, F8W720
Gene-Disease Assocation LEUKEMIA, ACUTE MYELOID; AML
Search EB-eye ENSG00000163655
Show more properties
Experimental Factors
Organism part

studied in E-MEXP-1251, E-GEOD-1563, E-GEOD-6919, E-TABM-130, E-MEXP-1331, ... (16 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-4525, E-GEOD-19639, E-GEOD-7182, E-GEOD-3202, ... (32 experiments)

Factor Value U/D Experiments
LNCaP
3
E-GEOD-14990, E-GEOD-14464, E-GEOD-847
CCRFCEM
2
E-MTAB-37, E-GEOD-24147
HL-60
2
E-GEOD-24147, E-MTAB-37
K562
2
E-MTAB-37, E-GEOD-24147
MCF-7
2
E-GEOD-19639, E-GEOD-20081
SW480
2
E-MTAB-37, E-MEXP-1014
337 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-4219, E-GEOD-13909, E-GEOD-20677, E-GEOD-13987, ... (38 experiments)

Factor Value U/D Experiments
embryonic stem cell
2
E-MEXP-930, E-GEOD-26672
human embryonic stem cell
2
E-GEOD-20033, E-GEOD-18147
stromal cell
1
2
E-GEOD-1460, E-GEOD-3998, E-MEXP-2034
CXCR4 positive
1
E-GEOD-15893
M2 macrophage
1
E-GEOD-5099
hematopoietic
1
E-GEOD-9894
78 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-MEXP-1121, E-GEOD-16363, ... (56 experiments)

Factor Value U/D Experiments
control
1
3
E-GEOD-21912, E-GEOD-8121, E-GEOD-16363, E-GEOD-3185
head and neck squamous cell carcinoma
2
E-GEOD-6631, E-GEOD-2379
glioblastoma
2
E-GEOD-4290, E-MTAB-37
lung adenocarcinoma
2
E-MTAB-37, E-GEOD-2514
prostate carcinoma
2
E-GEOD-96, E-MEXP-2034
amelanotic skin melanoma
1
E-MTAB-37
100 more value(s).


Compound treatment

studied in E-GEOD-7400, E-TABM-782, E-TABM-868, E-MEXP-1958, E-MEXP-2590, ... (26 experiments)

Factor Value U/D Experiments
none
3
9
E-TABM-782, E-MEXP-1601, E-MEXP-1230, E-GEOD-6907, E-MEXP-1958, ... (12 experiments)
lipopolysaccharide
2
E-MEXP-1958, E-TABM-868
control - IL-1b
1
E-GEOD-7216
baseline sevoflurane
1
E-GEOD-4386
hydrogen peroxide
1
E-GEOD-5339
ZMYM2/FGFR1
1
E-GEOD-15811
37 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519
thapsigargin
1
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Classifier
studied in E-GEOD-3493

Clinical history
studied in E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-MEXP-1251, E-GEOD-21589, ... (8 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-5999, E-GEOD-1614, E-GEOD-20033, E-GEOD-3140, E-MEXP-2359 ... (5 experiments)

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-22148, E-TABM-147, E-GEOD-21887, ... (7 experiments)

Environmental stress
studied in E-GEOD-1643

Er ihc
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, ... (7 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-3494, E-GEOD-2466, E-GEOD-17476, E-GEOD-18736, ... (12 experiments)

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-GEOD-7011, E-GEOD-22278, E-GEOD-10315, E-MEXP-1273, E-TABM-263, ... (14 experiments)

Histology
studied in E-TABM-234, E-TABM-276, E-GEOD-2748

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-5764, E-TABM-740, E-GEOD-1926, ... (30 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-12108, E-MEXP-561, E-GEOD-980, E-GEOD-6802, ... (6 experiments)

Injury
studied in E-GEOD-19743

Irradiate
studied in E-TABM-321

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Light
studied in E-GEOD-1725

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-AFMX-1, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-GEOD-22309, E-GEOD-21750, E-GEOD-1460, E-MEXP-1403 ... (5 experiments)

Population
studied in E-MTAB-197, E-GEOD-4922

Pr ihc
studied in E-GEOD-21653

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246 ... (5 experiments)

Replicate
studied in E-GEOD-10896

RNAi
studied in E-MEXP-2115, E-GEOD-12438, E-GEOD-1676, E-MEXP-1857, E-MEXP-1315 ... (5 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-17400, E-GEOD-18995

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-1643, E-GEOD-2466, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-13909, E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Test result
studied in E-TABM-276, E-GEOD-2748

Tissue
studied in E-GEOD-30573

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-33562, E-GEOD-16837, E-GEOD-19246, E-GEOD-13818, E-GEOD-19815, ... (7 experiments)

Tumor grading
studied in E-GEOD-4290, E-GEOD-6532, E-GEOD-4922, E-TABM-147

Tumor size
studied in E-GEOD-4922

Processing time: 0.26 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM